On November 26, Bosera Pharmaceutical 50 ETF (159838) closed up 0.73%, with a turnover of 8.2778 million yuan.
Pharmaceutical 50 ETF (159838) was established on July 22, 2021, and the full name of the fund is Bosera CSI Pharmaceutical 50 Exchange-traded Open-ended Index Securities Investment Fund, and the fund is referred to as Bosera Pharmaceutical 50 ETF. The fund has a management fee of 0.50% per annum and a custody fee of 0.10% per annum. The performance benchmark of the Pharmaceutical 50 ETF (159838) is the return rate of the CSI Pharmaceutical 50 Index.
In terms of scale, as of November 25, the latest share of Pharmaceutical 50 ETF (159838) was 414 million shares, and the latest scale was 226 million yuan. Looking back on December 29, 2023, the share of Pharmaceutical 50 ETF (159838) was 367 million shares, and the scale was 229 million yuan. That is, the share of the fund has increased by 12.81% since the beginning of this year, and the scale has decreased by 1.10%.
In terms of liquidity, as of November 26, the cumulative turnover of Pharmaceutical 50 ETF (159838) in the past 20 trading days was 201 million yuan, with an average daily turnover of 10.0422 million yuan, and since the beginning of this year, the cumulative turnover of 217 trading days has been 1.009 billion yuan, with an average daily turnover of 4.648 million yuan.
The current fund manager of Pharmaceutical 50 ETF (159838) is Zhao Yunyang. Zhao Yunyang has managed (or intends to manage) the fund since July 22, 2021, with a return of -45.26% during his tenure.
According to the latest regular report, the heavy stocks of the Pharmaceutical 50 ETF (159838) include Hengrui Pharmaceutical, WuXi AppTec, Mindray Medical, Pien Tze Huang, Aier Ophthalmology, United Imaging Medical, Aimeike, Kelun Pharmaceutical, Changchun High-tech, and Wantai Biotechnology, with the following proportions.
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 600276 | Hengrui Pharmaceutical | : 11.29%, | 481,700, 481,700, | |
| 603259 | WuXi AppTec | ,10.00%, | 426,222,314,800 | |
| 300760 | Mindray Medical | 8.91% | 67,9019,894,700 | |
| 600436 | Pien Tze Huang | 5.86% | 50,613,079,600||
| 300015 | Aier Ophthalmology | 5.61% | 787,0012,521,200 | |
| 688271 | United Imaging Medical | 3.22% | 56,27,188,500 | |
| 300896 | Aimeike | : 2.73%, | 25,8608.79 | million |
| 002422 | Kelun Pharmaceutical | , 2.71%, | 189,206,054,400 | |
| 000661 | Changchun High-tech | 2.65%, | 53,995,923,100||
| 603392 | Wantai Biotech | 2.37%, | 64,55281,300 |
Risk Warning: The market is risky, and investment needs to be cautious. This article is automatically released by the AI model, and any information appearing in this article (including but not limited to individual stocks, comments, forecasts, charts, indicators, theories, any form of expression, etc.) is for reference only and does not constitute personal investment advice. The MACD golden cross signal is formed, and these stocks are rising well!
Ticker Name
Percentage Change
Inclusion Date
